Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emerald Health Therapeutics Inc
(OP:
EMHTF
)
N/A
UNCHANGED
Last Price
Updated: 3:42 PM EST, Nov 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Emerald Health Therapeutics Inc
Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
November 10, 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
October 18, 2022
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
September 30, 2022
San Diego, California--(Newsfile Corp. - September 30, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical...
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
August 31, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or...
Via
Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
August 26, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company")...
Via
Newsfile
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
August 19, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
July 11, 2022
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
July 04, 2022
Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
May 12, 2022
Arrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to...
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
Emerald Health Therapeutics Sells Patents to FlowerPod
January 11, 2022
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
November 29, 2021
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Cannabis
Exposures
COVID-19
Cannabis
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
November 03, 2021
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and...
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
October 28, 2021
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announces that...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Emerald Health Therapeutics Announces Chief Financial Officer Transition
September 10, 2021
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today...
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
August 31, 2021
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Product Recall
Exposures
COVID-19
Cannabis
Intellectual Property
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
August 25, 2021
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Comments on Board Resignation
August 11, 2021
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Further to its press release of August 6th, Emerald Health Therapeutics,...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Hires VP Sales & Marketing
August 10, 2021
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed...
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
August 06, 2021
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility
July 23, 2021
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has retained...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Launches Fuse(TM) Lifestyle Brand with Fast-Acting Cannabis-Infused Beverage
July 21, 2021
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has introduced...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Reports 2021 First Quarter Financial Results and Provides Corporate Update
June 01, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Supply Chain
Exposures
COVID-19
Cannabis
Intellectual Property
Emerald Health Therapeutics Signs Letter of Intent for Product Co-Development Agreement with Prima Botanical Wellness Brand
May 25, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and The...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Supply Chain
Exposures
COVID-19
Cannabis
Intellectual Property
Emerald Health Therapeutics Licenses New Proprietary Cannabis Dried Flower Format Patent for use in United States
May 06, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer
May 04, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Mr....
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update
May 03, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Supply Chain
Exposures
COVID-19
Cannabis
Intellectual Property
Emerald Health Therapeutics Confirms Effective Listing Date on Canadian Securities Exchange
April 23, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald" or "the...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.